Fake medicines are now counted among the top money-making markets for crime groups in East Asia and the Pacific. This is the troubling news from a United Nations Office on Drugs and Crime (UNODC) report released Tuesday.
Guidance for Manufacturers : What is required to be ready to connect to the EMVS?
Brussels 16.04.13: The European Federation of Pharmaceutical Industries and Associations (EFPIA), with the support of its European Stakeholder Model partners, yesterday signed a contract with IT service provider Solidsoft to implement the European Medicines Ve
12.03.2013, Brussels: The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes today’s announcement of a new initiative from INTERPOL to fight the growing threat of fake medicines.
EFPIAs Director General Richard Bergström puts forward his views on the counterfeiting of medicines, the impact on patients, and what is being done to solve the problem.
Counterfeiting is an age old issue. It is now a global problem where every sector of our economy has been affected. However, the consequences are different when it comes to counterfeit medicines; the main concern is not so much the loss of revenue to our industry but the health of patients.
11.10.2012, Brussels: Interpol last week announced the seizure of over 3.75million units of counterfeit medicines worth over 10million USD. Operation Pangea V - the largest internet based action targeting black market and fake of illicit medicines- spanned over 100 countries and resulted in over 80 arrests. The operation ran from September 25 to October 2.
The European Association of Hospital Pharmacists (EAHP) and European Federation of Pharmaceutical and Industry Associations (EFPIA) have recently agreed to work towards a joint vision on the future of medicines bar coding to the single unit administered in hospitals.